JNK-IN-24
JNK-IN-24, a JNK inhibitor, is an anti-metastatic cancer agent. JNK-IN-24 downregulates JNK and MMP1 expression in Scrib knockdown induced cancer tissues. JNK-IN-24 promotes recovery from tumorous wing disc phenotype of ScribRNAi. JNK-IN-24 can be used for the study in various epithelial cell-derived cancers.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2226808-28-0
- Formel: C19H17ClO5
- Molecular Weight:360.79
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
JNK-IN-24 (250-1000 μM, incorporated into a corn agar-based food medium, 36 h) rescues early pupal deaths to fully differentiated into pharate adults and promotes recovery from tumorous wing disc phenotype of ScribRNAi[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Knockdown Scrib in wing imaginal discs[1]
-
Dosage:250, 1000 μM
-
Administration:Incorporated into a corn agar-based food medium for 36 h
-
Result:Exhibited significantly reduced Scrib transcript levels.
Decreased the levels of JNK and MMP1.
Restricted cancer cell migration from across anterior to posterior boundary.
Chemical Information
-
CAS. Nr. 2226808-28-0
-
Molecular Weight 360.79
-
Formel C19H17ClO5
-
SMILES
O=C(C1=C(C)OC2=C(C(O)=CC(O)=C2)C1C3=CC=C(Cl)C=C3)OCC
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)